ライフサイエンスコーパス: Denmark

1 5.3 (The Cochrane Collaboration, Copenhagen, Denmark).

2 ent latex kit (Statens Serum Institut [SSI], Denmark).

3 retinal clinic, Zealand University Hospital, Denmark.

4 he Netherlands, while numbers were stable in Denmark.

5 of patients with chronic retinal disease in Denmark.

6 ulticenter trial conducted at 9 hospitals in Denmark.

7 samples from Hong Kong, Austria, Germany and Denmark.

8 different university-affiliated hospitals in Denmark.

9 European Commission and The Innovation Fund Denmark.

10 amine infertility among male firefighters in Denmark.

11 trol group) from 2007 to 2016 in Copenhagen, Denmark.

12 undergone neither surgery (controls), all in Denmark.

13 V13) in the childhood vaccination program in Denmark.

14 ney samples from Finland, Sweden, Norway and Denmark.

15 1 102 women) aged 15-94 years were living in Denmark.

16 logy, Zealand University Hospital, Roskilde, Denmark.

17 Control, Statens Serum Institut, Copenhagen, Denmark.

18 dministrative and public health registers in Denmark.

19 be more widespread in Great Britain than in Denmark.

20 y, the United Kingdom, Ireland, Hungary, and Denmark.

21 ndiagnosed COPD in the general population in Denmark.

22 ality among patients with prostate cancer in Denmark.

23 ldren (n = 6090) born in 2000 in Copenhagen, Denmark.

24 e being launched in many countries including Denmark.

25 All transfusion recipients in Sweden and Denmark.

26 diagnosed between 2000 and 2012 in Northern Denmark.

27 mmon database at Rigshospitalet, Copenhagen, Denmark.

28 n the Central Region (Region Midtjylland) of Denmark.

29 national data (population: 5.2 million) from Denmark.

30 enrolled participants at 2 clinical sites in Denmark.

31 tional health registers from 1977 to 2012 in Denmark.

32 inhabitants of Lombardia and 5.5 million of Denmark.

33 gned to all live births and new residents in Denmark.

34 2000-2009, in Lombardia, Northern Italy, and Denmark.

35 the Psychiatric Central Research Register in Denmark.

36 diation levels and one control study site in Denmark.

37 gnancy and spontaneous loss for all women in Denmark.

38 orders extended across the Atlantic Ocean to Denmark.

39 ence of treatment-demanding ROP over time in Denmark.

40 a A(H10N7) virus, was reported in Sweden and Denmark.

41 Participants: Register-based cohort study in Denmark.

42 ttacks on mental disorders in the Kingdom of Denmark.

43 from 2008 to 2017, in the Capital Region of Denmark.

44 e sector within a small geographical area of Denmark.

45 (95% CI: 3 to 5 percentage points [p.p.]) in Denmark.

46 ash dieback sampled from sites in the UK and Denmark.

47 one in the Netherlands, the USA, Sweden, and Denmark.

48 00 year-old piece of chewed birch pitch from Denmark.

49 death occurring at <45 years of age (0.21 in Denmark; 0.26 in Scotland), higher for death occurring a

50 for death occurring at 45-59 years (0.69 in Denmark; 0.69 in Scotland), and highest for death at 60+

51 , and highest for death at 60+years (0.92 in Denmark; 0.75 in Scotland).

52 country at age six (N(Sweden) = 2,535,191, N(Denmark) = 1,382,367).

53 on-based cohort study of all persons born in Denmark 1967 through 1997, followed up from their 15th b

54 ll patients with first-time brain abscess in Denmark, 1982-2016.

55 f individuals born in Sweden (1977-2003) and Denmark (1984-2006) and still residing in their respecti

56 Nationwide register-based cohort study in Denmark, 1997-2013.

57 Healthy neonates were randomized 1:1 to BCG-Denmark (2,851 randomized, 2,840 analyzed) versus BCG-Ru

58 r-based cohort study in Sweden (2006-16) and Denmark (2000-16).

59 surgical resection in Sweden, 2009-2017 and Denmark 2016-2018.

60 Healthy neonates were randomized 1:1 to BCG-Denmark (2851 randomized, 2840 analyzed) vs BCG-Russia (

61 wed up in a diverticular disease sample from Denmark (5,970 cases, 3,020 controls).

62 wer in England (63.9%, 95% CI 63.5-64.3) and Denmark (65.7%, 64.7-66.8) than in Norway (69.5%, 68.4-7

63 9.1-70.3) than in the other three countries (Denmark 72.5%, 71.1-74.0; Sweden 74.1%, 72.7-75.4; and N

64 olorectal adenocarcinoma: 12 958 patients in Denmark, 97 466 in England, 11 450 in Norway, and 17 583

65 e rates among first-generation immigrants in Denmark, a high-incidence country, and their Danish-born

66 recent history of female life expectancy in Denmark, a saga of rising, stagnating, and now again ris

67 In Denmark, a total of 68 939 individuals (mean age, 42 yea

68 dy, national data on all individuals born in Denmark after 1981 and diagnosed with severe mental diso

69 Highly peaceful countries (Denmark) also may need less ambivalence because most gro

70 It appears that in Denmark, ambient stressors as common as increasing unemp

71 0, 2014, at Bispebjerg Hospital, Copenhagen, Denmark, among 12 healthy volunteers 18 years or older.

72 1.05 (99% confidence interval, 1.03-1.07) in Denmark and 1.01 (.98-1.05) in the United Kingdom.

73 dmissions among neonates vaccinated with BCG-Denmark and 130 admissions for BCG-Russia, IRR=1.08 (95%

74 Among children born in Denmark and aged 0-5 years, we aimed to compare anthropo

75 BCG-Denmark and BCG-Japan induced more BCG scars and PPD rea

76 BCG-Denmark and BCG-Japan were more immunogenic than BCG-Rus

77 dmissions among neonates vaccinated with BCG-Denmark and BCG-Russia, respectively (IRR, 1.08 [95% con

78 s (Capsicum var.) grown in temperate climate Denmark and determined the contents of the four major ca

79 orectal cancer has been shown to be lower in Denmark and England than in comparable high-income count

80 Australia, Czechia, Hungary, Poland, Norway, Denmark and Finland experienced mortality changes that r

81 31, 2002, 1 291 679 individuals were born in Denmark and followed up in our population cohort (approx

82 3 population-based case-control studies from Denmark and France.

83 were obtained from the Geological Survey of Denmark and Greenland.

84 d Ruditapes spp., respectively) purchased in Denmark and Italy.

85 Among women attempting to conceive in Denmark and North America, diets high in GL, carbohydrat

86 cohorts of couples attempting to conceive in Denmark and North America.

87 .32 y(-1), Z(M) = 1.73-3.08 y(-1)) than from Denmark and Norway (Z(P) = 0-0.13 y(-1), Z(M) = 0.19-1.0

88 rn limit (colder and humid maritime regions; Denmark and Norway) will probably not show large changes

89 In a nationwide study of children in Denmark and Norway, we found exposure to systemic antibi

90 f skin and soft tissue infections (SSTIs) in Denmark and other European countries with industrial pig

91 were tested in two independent cohorts from Denmark and Scotland by assessing the areas under the re

92 729 persons diagnosed with HCV antibodies in Denmark and Scotland, respectively.

93 We used data from nationwide registers in Denmark and Sweden for the period from Jan 1, 2010, to D

94 wo-hundred eighty patients from 3 centers in Denmark and Sweden were randomized to either TAVR (n=145

95 the virus and the laws aiming to contain it: Denmark and Sweden were similarly exposed to the pandemi

96 duals from the total population registers of Denmark and Sweden, who were matched for sex, age, birth

97 Denmark and the Netherlands had the lowest PAF (0.0% eac

98 dom, France, Germany, Ireland, Spain, Italy, Denmark and the Netherlands.

99 ts with a primary total joint replacement in Denmark and the United Kingdom (n = 189,286; 1987-2012).

100 atasets identified single M1(UK) isolates in Denmark and the USA.

101 Gisozi, Burundi)- and high-input (Jyndevad, Denmark and Washington, United States) management sites.

102 HCC in 110,761 individuals from Copenhagen, Denmark, and 334,691 individuals from the UK Biobank.

103 Postlicensure studies in Australia, Denmark, and Canada have demonstrated vaccine effectiven

104 place at nine HSCT centres based in the USA, Denmark, and Germany.

105 allopurinol in patients with gout in the UK, Denmark, and Sweden.

106 erse samples from the United States, Canada, Denmark, and The Netherlands (n = 6,271), we show that i

107 n three of the five countries studied-India, Denmark, and the USA) showed sales restrictions were fol

108 e general pattern was similar for Sweden and Denmark, and we believe that similar patterns may be fou

109 In Denmark, antithrombotic drug use was associated with hig

110 hin Region Zealand and the Capital Region of Denmark (April 2015-August 2016).

111 eland, Germany, France, the Netherlands, and Denmark as most affected countries.

112 sclerosis risk among individuals who came to Denmark at a later age remained closer to that of their

113 le younger than 95 years of age who lived in Denmark at some point between Jan 1, 1995, and Dec 31, 2

114 tory bowel diseases at tertiary hospitals in Denmark, Australia, and New Zealand from March 2012 thro

115 The 6-week mortality did not differ: BCG-Denmark/BCG-Russia (MRR, 1.15 [95% CI, .74-1.80]); BCG-J

116 The 6-week mortality did not differ, BCG-Denmark/BCG-Russia MRR=1.15 (0.74-1.81); BCG-Japan/BCG-R

117 First-generation immigrants arriving in Denmark before age 15 years had a multiple sclerosis ris

118 c 30, 1998, who did not die or emigrate from Denmark before their 18th birthday or before study entry

119 s (n = 157,449) and the unemployment rate in Denmark beginning in January 1995 and ending in December

120 spective cohort study involving all women in Denmark between 15 and 49 years of age who had not had c

121 e identified 9 121 187 individuals living in Denmark between 1968 and 2015, including 1 176 419 first

122 g a first-time diagnosis of heart failure in Denmark between 1995 and 2012.

123 g all individuals aged 15-94 years living in Denmark between 1995 and 2014.

124 verified upper urinary tract cancer cases in Denmark between 2000 and 2012 from the Danish Cancer Reg

125 opulation time trend analyses carried out in Denmark between 2000 and 2014.

126 udy of all women aged 17-25 years, living in Denmark between 2006 and 2016.

127 we linked data on a cohort of women born in Denmark between Jan 1, 1980, and Dec 30, 1998, who did n

128 lion individuals 15 years or older living in Denmark between January 1, 1980, and December 31, 2011,

129 ge) that included 1 085 172 children born in Denmark between January 1, 1996, and December 31, 2012,

130 ntiepileptic drugs aged 15 years or older in Denmark between July 1997 and December 2015.

131 age occlusion at Aarhus University Hospital, Denmark, between 2010 and 2017.

132 non-therapeutic antibiotic use was banned in Denmark, bla(CTX-M) levels declined in M soils, suggesti

133 icide mortality reported a fall in deaths in Denmark, but there were also decreases in suicide deaths

134 cribed, general practices from four centres (Denmark, Cambridge [UK], Leicester [UK], and the Netherl

135 tients with CHC with or without cirrhosis in Denmark compared with the general population.

136 e UK (London, Birmingham, and Edinburgh) and Denmark (Copenhagen) were studied.

137 National Health Service Denmark, Danish Council for Strategic Research, Danish R

138 ith similar effects across United States and Denmark data sets, but the effect has modest magnitude,

139 rst suicide attempt, date of emigration from Denmark, date of death, or Dec 31, 2016, whichever came

140 2 decades, the incidence of heart failure in Denmark declined among older individuals (>50 years), bu

141 udy based on nationwide data from Sweden and Denmark describes the complete range of massive transfus

142 collected medical data from all hospitals in Denmark during 1980 to 2009.

143 dy included 9908 patients undergoing RYGB in Denmark during 2006 to 2010 and 99,080 matched general p

144 se, covering all HPeV infections detected in Denmark during 2009-2012 among children <5 years of age.

145 anish-born, non-Western immigrants living in Denmark during the entire follow-up period also showed a

146 ongitudinal cohort study of children born in Denmark during the period from 1980 to 2010 who were ali

147 n for infertility at Frederiksberg Hospital, Denmark, during 1977-2010, and 4,712 of these men were f

148 a, Brazil, Democratic Republic of the Congo, Denmark, Egypt, France, Germany, India, Norway, and Thai

149 cinoma from Jan 1, 2010, to Dec 31, 2012, in Denmark, England, Norway, and Sweden, from national colo

150 , Austria, Belgium, Croatia, Czech Republic, Denmark, Estonia, France, Germany, Greece, Italy, Israel

151 ase 2a trial in 25 secondary care centres in Denmark, Estonia, France, Germany, Italy, Latvia, Lithua

152 les originated from four European countries (Denmark, Estonia, Germany, and Sweden).

153 based cohort study used nationwide data from Denmark, Finland, and Sweden for patients having undergo

154 clinics) across Belgium, the Czech Republic, Denmark, Finland, France, Germany, Italy, the Netherland

155 nd Sri Lanka), and 11 high-income countries (Denmark, Finland, Germany, Greece, Hungary, Ireland, Jap

156 haemovigilance systems (Australia, Austria, Denmark, Finland, Greece, India, Ireland, Italy, Japan,

157 All-Nordic (Denmark, Finland, Iceland, Norway, and Sweden) populatio

158 s (US, Australia, Belarus, Germany, Belgium, Denmark, Finland, Norway, Canada, Poland, UK, Spain, Net

159 included those who had not been residents in Denmark for at least 1 year before VTE diagnosis, patien

160 trategic Research, Independent Research Fund Denmark, Forte Foundation, Swedish Cancer Foundation.

161 cases and 2,723 controls from 3 PD studies (Denmark, France) that obtained information on smoking th

162 ss 12 countries (Australia, Austria, Canada, Denmark, France, Germany, Italy, Poland, Russia, the Net

163 ntries (the USA, Australia, Belgium, Canada, Denmark, France, Germany, Sweden, and the UK).

164 gist, and pathologist, from seven countries (Denmark, France, Italy, Japan, Netherlands, Portugal, an

165 and August 2017 in 63 hospitals in Belgium, Denmark, France, the Netherlands, and the United States,

166 ata on more than 5.9 million persons born in Denmark from 1900 through 2015 and followed them from 20

167 A total of 3768943 individuals born in Denmark from 1955 to 2012 were followed up during the st

168 etrospective cohort-study, all women born in Denmark from 1962 to 1971 were eligible for inclusion an

169 hildren born to kidney-transplanted women in Denmark from 1964 to 2016 were identified in a nationwid

170 ildren (<18 years of age) treated for CHD in Denmark from 1977 to 2015, their need for reintervention

171 mosomal abnormalities lasting >/=20 weeks in Denmark from 1978 to 2011 (n= 1 972 857), we identified

172 In Denmark from 1980 through 2016, there was a significantl

173 We identified 1384 brain abscess patients in Denmark from 1982 through 2016, and 13 839 matched popul

174 We included all children born in Denmark from 1995 through 2012 or Norway from 2004 throu

175 disorders and sex in predicting dementia, in Denmark from 1995 to 2011.

176 rate transfusions in Sweden from 1987 and in Denmark from 1996.

177 All live-born singletons in Denmark from 1998 to 2007 were identified.

178 women with early breast cancer diagnosed in Denmark from 1998 to 2011.

179 All ICUs in Denmark from 2005 to 2013.

180 study that included 295559 children born in Denmark from April 2004 to December 2010.

181 th rCDI seen at a gastroenterology clinic in Denmark from April 5, 2016 through June 10, 2018.

182 mprising all live-born singleton children in Denmark from pregnancies overlapping the A(H1N1) influen

183 y on all persons 15 years or older living in Denmark, from 1980 through 2016 (N = 7 300 395).

184 of Microbiology, Odense University Hospital, Denmark, from 1995 through 2014.

185 edure in the lower extremities or abdomen in Denmark, from 2000 to 2016.

186 he A(H1N1) influenza vaccination campaign in Denmark, from November 2, 2009, to March 31, 2010.

187 tions in 5 countries (China, Czech Republic, Denmark, Germany, and the United States).

188 Australia, Belgium, Canada, Czech Republic, Denmark, Germany, Greece, Ireland, Israel, Italy, Poland

189 in 13 countries (Australia, Belgium, Canada, Denmark, Germany, Hungary, Israel, the Netherlands, New

190 ION-3) at 90 hospitals and cancer centres in Denmark, Germany, Italy, Japan, South Korea, Taiwan, the

191 academic centres in Belgium, Czech Republic, Denmark, Greece, Israel, Italy, Mexico, the Netherlands,

192 ed for 45 hospitals in Argentina, Australia, Denmark, Greece, Mexico, Spain, Thailand, UK, and the US

193 Since 1992, Denmark has documented the largest outbreak of tuberculo

194 referred to give birth at Hvidovre Hospital, Denmark, have been offered participation in the prospect

195 23,759 symptomatic patients from the Western Denmark Heart Registry who underwent diagnostic computed

196 omography for calcium scoring in the Western Denmark Heart Registry, from January 1, 2008 to December

197 f 2408 PD patients and 228,470 controls from Denmark, Iceland and the Netherlands.

198 weeks in 2013 from Finland, Sweden, Norway, Denmark, Iceland, Ireland, England, the Netherlands, Bel

199 e similarly exposed to the pandemic but only Denmark imposed significant restrictions on social and e

200 cohort containing 11640 individuals born in Denmark in 1955 or later with their first recorded MDD d

201 elineate a cohort of all individuals born in Denmark in 1967-2000, who were alive and residing in Den

202 ased cohort study of all individuals born in Denmark in 1978-2002.

203 nclude all 1,994,618 live singletons born in Denmark in 1981-2015.

204 included all singleton HEU children born in Denmark in 2000-2016.

205 Early administration of BCG-Denmark in LW infants is associated with major reduction

206 re >18 years of age and diagnosed with HF in Denmark in the period of January 1, 2003, to June 1, 201

207 irst Aarhus Immunotherapy Symposium (Aarhus, Denmark) in December 2015 by leading clinicians, scienti

208 013, we randomized LW neonates to "early BCG-Denmark" (intervention group; n = 2083) or "control" (lo

209 place in trial-accredited centres in Canada, Denmark, Ireland, and the UK.

210 increasing more than 13 percentage points in Denmark, Ireland, and the UK.

211 lia, Canada, and Norway than in New Zealand, Denmark, Ireland, and the UK.

212 tions in seven countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway, and the UK) for s

213 es of restrictions in five countries- India, Denmark, Ireland, the UK and the USA).

214 therapy (SLIT)-tablet (ALK-Abello, Horsholm, Denmark) is developed for treatment of tree pollen-induc

215 tion-based cohort study from five countries (Denmark, Israel, Norway, Sweden and Western Australia) c

216 , France, Italy, UK, Spain, the Netherlands, Denmark, Israel, Switzerland, and Germany).

217 omised trial in 23 hospitals across Belgium, Denmark, Italy, Netherlands, Slovenia, and United Kingdo

218 If BTV is introduced in Denmark, local transmission is very likely to occur.

219 led trials (RCTs) have demonstrated that BCG-Denmark lowers all-cause mortality, but a recent RCT fou

220 lled trials (RCTs) has demonstrated that BCG-Denmark lowers all-cause mortality, but a recent RCT fou

221 e-cohort design included all persons born in Denmark (N = 1683385) between January 1, 1967, and Decem

222 re or hospital-based setting in 1997-2013 in Denmark (n = 190671) and 2000-2013 in the United Kingdom

223 rospective data sets from Finland (n = 860), Denmark (n = 453), and Scotland (n = 231).

224 In Denmark (n=2 824 199 individuals; 5397 incident pacemake

225 d cohort study of 96 447 patients with UC in Denmark (n=32 919) and Sweden (n=63 528), patients were

226 s (the United States, Scotland, England, and Denmark; n = 1958) from March 2014 through March 2015.

227 or "control" (local policy for LW and no BCG-Denmark; n = 2089) at discharge from the maternity ward

228 s this need and have presented findings from Denmark, Norway, and Sweden, where it was piloted.

229 Registers, and National Patient Registers in Denmark, Norway, and Sweden.

230 de, register-based cohort study conducted in Denmark of 6.7 million individuals aged 18 years and old

231 This was a cohort study, conducted in Denmark, of 33,555 five-year survivors of adolescent or

232 ETHOD: The study followed all people born in Denmark on or after Jan.

233 in 1967-2000, who were alive and residing in Denmark on their 15th birthday, and who had been dischar

234 heir country of birth but lower than that in Denmark, reaching on average 69% of the multiple scleros

235 alysis of 3 BCG trials showed that early BCG-Denmark reduced mortality by 38% (MRR, 0.62; 95% CI, .46

236 the present trial to test whether early BCG-Denmark reduces neonatal mortality by 45%.

237 ecialist practitioner clinics in the Central Denmark Region were invited to be tested by a commercial

238 dation, Danish Epilepsy Association, Central Denmark Region, Lundbeck Foundation, and Stanley Medical

239 eden, Cambodia, United Kingdom, Switzerland, Denmark, Rwanda, and Namibia) were within 12% and 10% of

240 p to the 2009 introduction of HPV vaccine to Denmark's vaccination program.

241 d-linked birth and hospitalisation data from Denmark, Scotland, England, and Australia (New South Wal

242 ve cohort study at 2 university hospitals in Denmark, screening all patients for toxigenic C difficil

243 sh registers and included all people born in Denmark since 1981.

244 derived from preconception cohort studies in Denmark (Snart Foraeldre) and North America [PRESTO (Pre

245 omogeneous (Caucasian diabetes patients from Denmark) so the resulting stratification is not driven b

246 tre, the Cochrane Collaboration, Copenhagen, Denmark) software.

247 DI-2/ERIC-PPCI) at 33 centres across the UK, Denmark, Spain, and Serbia.

248 lon cancer was also lower in England than in Denmark (stage II rectal cancer 91.2%, 88.8-93.1; and st

249 domized trials in Guinea-Bissau of early BCG-Denmark (Statens Serum Institut) given to low-weight (LW

250 data, to elucidate the source regions of the Denmark Strait and Faroe Bank Channel overflows and the

251 ward along the slope north of Iceland toward Denmark Strait.

252 5 622 patients in the United States, Norway, Denmark, Sweden, and the United Kingdom, death occurred

253 137)Cs ratios in soil samples collected from Denmark, Sweden, and Ukraine.

254 eriority trial in 15 university hospitals in Denmark, Sweden, Finland, Norway, and the USA enrolled w

255 l registries from the United States, Norway, Denmark, Sweden, Germany, and the United Kingdom.

256 a case of Odense, the third largest city in Denmark that is undergoing major construction works.

257 linics in five countries (Australia, Canada, Denmark, the Netherlands, and the UK).

258 eral societies' guidelines and statements in Denmark, the United Kingdom, Europe, Canada, Brazil, and

259 Among children born in Denmark, the use of frozen embryo transfer, compared wit

260 In Denmark there were 722 cases of incident PBC, female:mal

261 nhagen University Hospital in Frederiksberg, Denmark; they had previously completed a 68-wk lifestyle

262 , individually matched case-control study in Denmark to assess whether hospitalization for trauma is

263 rdiac arrest after nationwide initiatives in Denmark to facilitate bystander-mediated resuscitative e

264 e data on out-of-hospital cardiac arrests in Denmark to functional outcome data and reported the 1-ye

265 A fast-track pathway has been established in Denmark to investigate patients with serious nonspecific

266 on a seabed sediment sample (Roskilde Fjord, Denmark) to demonstrate the method efficiency.

267 o Western Europe, from Sweden via Norway, to Denmark, to the Netherlands.

268 also conducted a meta-analysis of the 3 BCG-Denmark trials.

269 fallow (vegetation-free) plots at six sites: Denmark (two sites), France, Russia, Sweden and the Unit

270 ased follow-up study of Covid-19 patients in Denmark until May 16, 2020.

271 d the phthalate content of drugs marketed in Denmark using an internal Danish Medicines Agency ingred

272 Denmark was accidentally deleted during the conversion o

273 Denmark was accidentally deleted during the conversion o

274 Early administration of BCG-Denmark was associated with a nonsignificant reduction i

275 referral centers in the United States and in Denmark was conducted from June 1, 2016, to March 31, 20

276 Information from Denmark was from the Danish Breast Cancer Cooperative Gr

277 Halfway through the trial, production of BCG-Denmark was halted, and the trial continued comparing BC

278 Halfway through the trial, production of BCG-Denmark was halted, and the trial continued comparing BC

279 rectal cancer in England and colon cancer in Denmark was lower than in Norway and Sweden.

280 population-based prospective cohort study in Denmark, we found that asymptomatic carriers of toxigeni

281 03), a prospective study of elderly women in Denmark, we found that impaired fasting plasma glucose c

282 rements across La Rioja province (Spain) and Denmark, we investigate how various properties of forest

283 In a study of incident CRC cases in Denmark, we observed that tumors found in patients who h

284 g-lived individuals born in 1905 and 1915 in Denmark, we performed survival analysis to estimate risk

285 since 1923 at Askov Experimental Station in Denmark, we quantified four broad-spectrum beta-lactam A

286 Children born in Denmark were followed until May 8, 2015 (age at end of f

287 cents aged 15 to 34 years who were living in Denmark were followed up from January 1, 2000, to Decemb

288 Species declining in Denmark were found to be in similar decline all over Nor

289 Trainees from 4 University Hospitals in East Denmark were included (N = 54).

290 mber 31, 2010, obtained residency permits in Denmark were included and matched in a 1 : 6 ratio on ag

291 ndividual-level exposure to air pollution in Denmark were used to assess the association between poll

292 00 suicides per 100 000 prisoners apart from Denmark (where it was 91 per 100 000), followed by weste

293 n, USA, and Herlev and Gentofte, Copenhagen, Denmark - which are linked by the pre-existing CopMich C

294 ssed a cohort that included all the women in Denmark who had a pregnancy ending between October 1, 20

295 ide prospective cohort study of all women in Denmark who had no psychiatric diagnoses, antidepressant

296 h registers was conducted of all patients in Denmark who received a diagnosis between January 1, 1994

297 ationwide study identified 18688 patients in Denmark with first-time OHCA from June 1, 2001, to Decem

298 s composed of approximately 30% of births in Denmark, with a boy-girl ratio of 51:49.

299 We hypothesized that BCG-Denmark would reduce morbidity (primary outcome) and mor

300 We hypothesized that BCG-Denmark would reduce morbidity (primary outcome) and mor